Ribon Therapeutics
Pioneering Therapeutics Targeting Cellular Stress Pathways
Cambridge, United States
9 employees
Venture round
Total: $259.00M
Biotechnology, Health Care
General Information
Cambridge, United States
BounceWatch is an independent company data service, not affiliated with Ribon Therapeutics. To contact Ribon Therapeutics, visit ribontx.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does Ribon Therapeutics compare?
A PDF of Ribon Therapeutics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting Ribon Therapeutics soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
From the desk
Is Ribon Therapeutics on your competitive set?
Our desk can watch it and brief you on every move: hiring, funding, leadership, product and pricing.
Book a 7-day ReadoutDiscover More
United States Market
Biotechnology
About Ribon Therapeutics
Business keywords: clinical-stage, small molecule inhibitors, cancer cells, cellular stress pathways, PARP proteins, cancer medicines, drug discovery, monoPARPs, cancer treatment, molecular action, biology, proprietary drug discovery platform, life science investors, therapeutics
Funding Rounds & Investors (7)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Venture Round | $25.00M | 1 |
Pfizer Venture Investments
|
22 Dec 2022 |
| Debt Financing | $50.00M | 1 |
|
26 Apr 2022 |
| Series C | $65.00M | 10 |
|
14 Jun 2021 |
| Series B | $65.00M | 9 |
|
04 Jan 2019 |
| Venture Round | $20.00M | - |
|
10 Oct 2017 |
| Series A | $24.00M | 5 |
|
01 Feb 2016 |
| Venture Round | $10.00M | 3 |
|
16 Dec 2015 |
Ribon Therapeutics Alternatives & Competitors
View All Alternatives
Modulating DNA damage responses to cure cancer
Pioneering novel therapies with promising small molecule kinase inhibitors for a brighter future in...
VCP/p97 Inhibitors for Oncology and Neurodegenerative Diseases
FAQ About Ribon Therapeutics
Source: BounceWatch company record for Ribon Therapeutics, https://bouncewatch.com/company/ribon-therapeutics, updated 6 January 2025. When citing, please name BounceWatch and link this page.
